Cargando…
miR-216a-5p inhibits malignant progression in small cell lung cancer: involvement of the Bcl-2 family proteins
OBJECTIVE: microRNAs are regulatory molecules regarded as important in the pathogenesis of different types of tumors. microRNA-216a (miR-216a-5p) has been identified as a tumor suppressor in multiple malignancies. However, the role of miR-216a-5p in the pathogenesis of small cell lung cancer (SCLC)...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201844/ https://www.ncbi.nlm.nih.gov/pubmed/30425570 http://dx.doi.org/10.2147/CMAR.S178380 |
_version_ | 1783365581515259904 |
---|---|
author | Sun, Yanqin Hu, Bingshuang Wang, Yanhong Li, Zhen Wu, Jingfang Yang, Yunchu Wei, Yue Peng, Xiaofeng Chen, Hongling Chen, Rongqi Jiang, Pingyan Fang, Sixian Yu, Zhiwu Guo, Linlang |
author_facet | Sun, Yanqin Hu, Bingshuang Wang, Yanhong Li, Zhen Wu, Jingfang Yang, Yunchu Wei, Yue Peng, Xiaofeng Chen, Hongling Chen, Rongqi Jiang, Pingyan Fang, Sixian Yu, Zhiwu Guo, Linlang |
author_sort | Sun, Yanqin |
collection | PubMed |
description | OBJECTIVE: microRNAs are regulatory molecules regarded as important in the pathogenesis of different types of tumors. microRNA-216a (miR-216a-5p) has been identified as a tumor suppressor in multiple malignancies. However, the role of miR-216a-5p in the pathogenesis of small cell lung cancer (SCLC) remains obscure. The objective of this study was to investigate the role of the miR-216a-5p/Bcl-2 axis in SCLC pathogenesis. MATERIALS AND METHODS: All the experimental methods used were as follows: microarray analysis, cell culture, transient, and stable gene transfection; real-time fluorescence PCR; Western blot; flow cytometry for cell cycle analysis; in vitro proliferation assay; in vitro wound healing experiment; in vivo xenograft model in nude mice; and dual luciferase reporter assay. All statistical analyses were carried out using GraphPad Prism 7 software. Statistical significance was analyzed by Student’s t-test or one-way ANOVA. P <0.05 (typically compared with the negative control group) was considered as significant and is marked with an asterisk in the figures. RESULTS: In this study, we observed that miR-216a-5p is downregulated in SCLC cell lines compared to that in the normal human bronchial epithelial cell line 16-HBE. In vitro and in vivo experiments demonstrate that upregulation of miR-216a-5p significantly decreased cell growth and migration and its downregulation increased SCLC cell proliferation and migration and influenced the cell cycle. Using bioinformatics analyses, we predicted that the important antiapoptotic gene Bcl-2 is targeted by miR-216a-5p, and we identified a functional miR-216a-5p binding site in the 3′-UTR of Bcl-2 using luciferase reporter assay. Furthermore, we determined that suppression of miR-216a-5p modulated the expression of Bcl-2, Bax, and Bad proteins (Bcl-2 family proteins), while Bcl-2 knockdown abrogated the effect of miR-216a-5p downregulation on cell proliferation, cell migration, and the cell cycle. CONCLUSION: Taken together, these findings suggest that miR-216a-5p regulates SCLC biology via Bcl-2 family proteins. Therefore, our study highlights the role of the miR-216a-5p/Bcl-2 axis in SCLC pathogenesis. |
format | Online Article Text |
id | pubmed-6201844 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-62018442018-11-13 miR-216a-5p inhibits malignant progression in small cell lung cancer: involvement of the Bcl-2 family proteins Sun, Yanqin Hu, Bingshuang Wang, Yanhong Li, Zhen Wu, Jingfang Yang, Yunchu Wei, Yue Peng, Xiaofeng Chen, Hongling Chen, Rongqi Jiang, Pingyan Fang, Sixian Yu, Zhiwu Guo, Linlang Cancer Manag Res Original Research OBJECTIVE: microRNAs are regulatory molecules regarded as important in the pathogenesis of different types of tumors. microRNA-216a (miR-216a-5p) has been identified as a tumor suppressor in multiple malignancies. However, the role of miR-216a-5p in the pathogenesis of small cell lung cancer (SCLC) remains obscure. The objective of this study was to investigate the role of the miR-216a-5p/Bcl-2 axis in SCLC pathogenesis. MATERIALS AND METHODS: All the experimental methods used were as follows: microarray analysis, cell culture, transient, and stable gene transfection; real-time fluorescence PCR; Western blot; flow cytometry for cell cycle analysis; in vitro proliferation assay; in vitro wound healing experiment; in vivo xenograft model in nude mice; and dual luciferase reporter assay. All statistical analyses were carried out using GraphPad Prism 7 software. Statistical significance was analyzed by Student’s t-test or one-way ANOVA. P <0.05 (typically compared with the negative control group) was considered as significant and is marked with an asterisk in the figures. RESULTS: In this study, we observed that miR-216a-5p is downregulated in SCLC cell lines compared to that in the normal human bronchial epithelial cell line 16-HBE. In vitro and in vivo experiments demonstrate that upregulation of miR-216a-5p significantly decreased cell growth and migration and its downregulation increased SCLC cell proliferation and migration and influenced the cell cycle. Using bioinformatics analyses, we predicted that the important antiapoptotic gene Bcl-2 is targeted by miR-216a-5p, and we identified a functional miR-216a-5p binding site in the 3′-UTR of Bcl-2 using luciferase reporter assay. Furthermore, we determined that suppression of miR-216a-5p modulated the expression of Bcl-2, Bax, and Bad proteins (Bcl-2 family proteins), while Bcl-2 knockdown abrogated the effect of miR-216a-5p downregulation on cell proliferation, cell migration, and the cell cycle. CONCLUSION: Taken together, these findings suggest that miR-216a-5p regulates SCLC biology via Bcl-2 family proteins. Therefore, our study highlights the role of the miR-216a-5p/Bcl-2 axis in SCLC pathogenesis. Dove Medical Press 2018-10-18 /pmc/articles/PMC6201844/ /pubmed/30425570 http://dx.doi.org/10.2147/CMAR.S178380 Text en © 2018 Sun et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Sun, Yanqin Hu, Bingshuang Wang, Yanhong Li, Zhen Wu, Jingfang Yang, Yunchu Wei, Yue Peng, Xiaofeng Chen, Hongling Chen, Rongqi Jiang, Pingyan Fang, Sixian Yu, Zhiwu Guo, Linlang miR-216a-5p inhibits malignant progression in small cell lung cancer: involvement of the Bcl-2 family proteins |
title | miR-216a-5p inhibits malignant progression in small cell lung cancer: involvement of the Bcl-2 family proteins |
title_full | miR-216a-5p inhibits malignant progression in small cell lung cancer: involvement of the Bcl-2 family proteins |
title_fullStr | miR-216a-5p inhibits malignant progression in small cell lung cancer: involvement of the Bcl-2 family proteins |
title_full_unstemmed | miR-216a-5p inhibits malignant progression in small cell lung cancer: involvement of the Bcl-2 family proteins |
title_short | miR-216a-5p inhibits malignant progression in small cell lung cancer: involvement of the Bcl-2 family proteins |
title_sort | mir-216a-5p inhibits malignant progression in small cell lung cancer: involvement of the bcl-2 family proteins |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201844/ https://www.ncbi.nlm.nih.gov/pubmed/30425570 http://dx.doi.org/10.2147/CMAR.S178380 |
work_keys_str_mv | AT sunyanqin mir216a5pinhibitsmalignantprogressioninsmallcelllungcancerinvolvementofthebcl2familyproteins AT hubingshuang mir216a5pinhibitsmalignantprogressioninsmallcelllungcancerinvolvementofthebcl2familyproteins AT wangyanhong mir216a5pinhibitsmalignantprogressioninsmallcelllungcancerinvolvementofthebcl2familyproteins AT lizhen mir216a5pinhibitsmalignantprogressioninsmallcelllungcancerinvolvementofthebcl2familyproteins AT wujingfang mir216a5pinhibitsmalignantprogressioninsmallcelllungcancerinvolvementofthebcl2familyproteins AT yangyunchu mir216a5pinhibitsmalignantprogressioninsmallcelllungcancerinvolvementofthebcl2familyproteins AT weiyue mir216a5pinhibitsmalignantprogressioninsmallcelllungcancerinvolvementofthebcl2familyproteins AT pengxiaofeng mir216a5pinhibitsmalignantprogressioninsmallcelllungcancerinvolvementofthebcl2familyproteins AT chenhongling mir216a5pinhibitsmalignantprogressioninsmallcelllungcancerinvolvementofthebcl2familyproteins AT chenrongqi mir216a5pinhibitsmalignantprogressioninsmallcelllungcancerinvolvementofthebcl2familyproteins AT jiangpingyan mir216a5pinhibitsmalignantprogressioninsmallcelllungcancerinvolvementofthebcl2familyproteins AT fangsixian mir216a5pinhibitsmalignantprogressioninsmallcelllungcancerinvolvementofthebcl2familyproteins AT yuzhiwu mir216a5pinhibitsmalignantprogressioninsmallcelllungcancerinvolvementofthebcl2familyproteins AT guolinlang mir216a5pinhibitsmalignantprogressioninsmallcelllungcancerinvolvementofthebcl2familyproteins |